|
Daily aspirin cuts bowel cancer death risk
Friday April 27, 2012 08:51:48 AM,
IANS
|
|
|
|
|
London:
People suffering from bowel cancer who take aspirin daily could
cut their chance of dying from the disease by about one-third, a
decade-long study has said.
The study in the British Journal of Cancer looked at 4,500 bowel
cancer patients living in the Netherlands, BBC reported.
All the bowel patients took a low dose of aspirin -- 80 mg or less
a day. This dose is already recommended for people with heart
disease.
Evidence suggests aspirin might prevent certain cancers from
developing in the first place. Some research also suggest aspirin
might work as a cancer therapy -- that slows down or prevents
cancer's spread.
But the experts said it was too soon to start routinely offering
it for bowel cancer.
The drug can have unpleasant and dangerous side effects, causing
irritation of the stomach lining and internal bleeding.
In the study, a quarter of the patients did not use aspirin, a
quarter only took aspirin after being diagnosed with bowel cancer,
and the remaining half took aspirin both before and after their
diagnosis.
Most of the patients on aspirin had been taking it to prevent
cardiovascular disease-related problems like heart attack.
It was found that taking aspirin for any length of time after
diagnosis cut the chance of dying from bowel cancer by 23 percent.
The patients who took a daily dose of aspirin for at least nine
months after their diagnosis cut their chance of dying from the
disease by 30 percent.
Taking aspirin only after bowel cancer had been detected had a
bigger impact on reducing mortality compared to when aspirin was
taken before and after diagnosis -- reducing death risk by 12
percent.
"Our work adds to growing evidence that aspirin not only can
prevent cancer from occurring but if it is there it can help
prevent it spreading," said lead researcher Gerrit-Jan Liefers, of
the Leiden University Medical Centre.
He, however, said aspirin should not be seen as an alternative to
other treatments, such as chemotherapy.
|
|
Home |
Top of the Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Top Stories |
|
 Gilani convicted for contempt of court
Pakistani Prime Minister Yousuf Raza Gilani was convicted Thursday
for contempt of court by the Supreme Court for refusing to write
to the Swiss authorities to reopen a corruption case against
President
»
Contempt case: SC to decide Gilani's fate today
First for Pakistan, PM indicted for contempt
|
|
|
|
Most Read |
|
 Risat-1 launch successful, India hurled into a select group of nations
On an early Thursday morning, an Indian rocket
successfully launched into orbit a microwave Radar Imaging
Satellite (Risat-1) from the spaceport here in Andhra
»
|
|
 Activists blame government, police for Hyderabad riots
Activists belonging to the Civil Liberties Monitoring Committee in
a fact finding report blamed the state government and the police
for the riots that spread in Hyderabad in second week of April.
They also accused Hindutva brigade of provocation and
»
|
|
|
|
News Pick |
|
Bofors storm rocks parliament, fresh probe
demanded
Almost a
quarter century after it surfaced, the Bofors payoff scandal
created a storm again Thursday disrupting parliament, as the
opposition
»
Bofors saga: a new twist and a story retold
|
|
'B' for bomb, 'ch' for chaku...in UP school
books
Upside down pictures of India's national flag, chapters to
teach the Hindi alphabet that say 'b' for 'bomb' and 'ch' for 'chaku'
(knife)...These glaring anomalies have surfaced in two textbooks
used in some Uttar Pradesh schools
»
|
|
 Hafeez Contractor plans Dubai-like 'New
Patna' on Ganges
Hafeez Contractor, one of India's best known architects, plans to
develop a world city alongside the river Ganges here - on the
lines of Dubai - that
»
|
|
|
|
Picture of the Day |
|
 |
|
India successfully flight-tested the Long Range Ballistic
Missile (LRBM) Agni-V (A-5) from wheeler’s island, in Odisha
on April 19, 2012. With the launch, India stormed into an
exclusive club of nations, including US, Russia and China.
(Photo: DPR (MOD))
|
|
|
|
|
Comments
|
Quick links